Searchable abstracts of presentations at key conferences in endocrinology

ea0028p43 | Clinical practice/governance and case reports | SFEBES2012

Disconnection hyperprolactinaemia in non-adenomatous sellar/parasellar lesions practically never exceeds 2000 mU/L

Korevaar Tim , Wass John , Grossman Ashley , Karavitaki Niki

Hyperprolactinaemia in association with a large sellar lesion could represent either tumoural secretion of prolactin (PRL) or stalk disruption by a non-prolactinoma: the differentiation has important therapeutic consequences. We have previously shown that based on currently used assays disconnection hyperprolactinaemia associated with non-functioning adenoma (NFA) practically never exceeds levels above 2000 mU/l. We aimed to verify our proposed disconnection hyperprolactinaemi...

ea0028p157 | Nursing practise | SFEBES2012

Outcome of patients with Graves’ disease after long-term follow-up: data from a Nurse-led Thyroid Clinic

Fazal-Sanderson Violet , Alberts Barbara , Grossman Ashley , Karavitaki Niki

A relapse rate of more than 50% is quoted for patients with Graves’ Disease (GD) treated with anti-thyroid drugs. Our aim was to audit the outcome/relapse rate and possible predictive factors in a series of patients managed in our Nurse-led Thyroid Clinic (NLTC). The notes of patients with newly-diagnosed GD seen in the NLTC between 2005–2011 who had completed 18 months of anti-thyroid drug were reviewed: 60 patients (48 females) were identified. After 18 months of t...

ea0025p42 | Clinical biochemistry | SFEBES2011

A review of the Endocrine Transition Service over the last 10 years

Ray Nilanjana , Davison Tania , Ryan Fiona , Wass John , Karavitaki Niki

Poor transitional care leads to increased loss to follow up, non-adherence to treatment, high morbidity and mortality. The paediatric and adult endocrinology teams in our Trust have been running a joint transition service since 10/2000. A review of this service was undertaken, in order to examine its effectiveness and to aid its improvement.The details of all 81 patients, who had been through transitional care between 10/00-09/09 were acquired. Their rec...

ea0025p68 | Clinical biochemistry | SFEBES2011

Improving communication in clinical care: a re-audit of an Endocrinology and Diabetes GP e-mail advisory service following commissioning

Alberts Barbara , Walker Neil , Karavitaki Niki , Levy Jonathan , Wass John

Introduction and aim: An e-mail based GP advisory service was launched by the authors’ centre in 2005. The PCT commissioned the service in July 2009. Enquiries are handled by specialist registrars with consultant supervision. The charge is £23/enquiry.Pre-commissioning, annual audits demonstrated an efficient and popular service, enhancing communication links between primary and secondary/tertiary care.We re-audited the s...

ea0025p168 | Endocrine tumours and neoplasia | SFEBES2011

Ectopic ACTH syndrome: experience of a tertiary referral centre: from diagnosis to outcome

Veloza Andreia , Ntali Georgia , Wass John , Karavitaki Niki

Introduction: Ectopic Cushing’s syndrome (ECS) accounts for approximately 10% cases of Cushing’s syndrome. Its recognition may be delayed and its diagnosis and treatment remain challenging.Aim: To analyze the clinical, biochemical, radiological features, as well as the outcome of patients with ECS presenting in a tertiary referral centre.Material and methods: The records of patients with ECS followed presenting in our Dep...

ea0025p211 | Nursing practise | SFEBES2011

Nebido (testosterone undecanoate) in patients over 60 years of age: a time to reduce dose frequency?

Mantripp Diana , Franklin Rachel , Wass John , Karavitaki Niki

Background: Clinical experience has shown that men over 60 years of age frequently (40%) require extended intervals of greater than 12 weeks between administrations of Nebido. No work has assessed whether this is specific to men over 60 years of age.Methods: We analysed men on Nebido over 60 years (n=12, mean age 66 years) and compared them with a BMI matched group aged 40–60 years. We assessed testosterone levels, injection intervals, PSA an...

ea0025p286 | Steroids | SFEBES2011

Steroid Replacement Education: Impact on Patients and their Carers

Saeed Mujahid , Aung Theingi , MacDonald Judy , Wass John , Karavitaki Niki

Steroid replacement is life-saving in patients with steroid axis deficiency; education surrounding steroid replacement is vital in their management.We organised ‘Steroid Replacement Education Days’ for patients and their family members/carers to help enhance their knowledge on steroids and intercurrent illness. Lectures detailed manifestations, causes, management of steroid deficiency and the practical issues surrounding steroid replacement. Th...

ea0025p307 | Steroids | SFEBES2011

Epidemiology of Addison's disease in the area of banbury, oxfordshire

Komninos John , Kohler Sybil , Karavitaki Niki , Wass John

Introduction: Addison’s disease (AD) is a rare condition (reported prevalence of 40–110 per million) that requires prompt recognition and optimal management to prevent the risks associated with cortisol deficiency.Aim: To assess the prevalence, presentation and clinical course of patients diagnosed with AD in the geographical area of Banbury in Oxfordshire.Patients and methods: Notes of subjects with AD currently register...

ea0024p55 | (1) | BSPED2010

A review of the endocrine transition service over the last 10 years

Davison T , Ray N , Ryan F , Karavitaki N

Transitional care has become a high priority for the Department of Health (1). The paediatric and adult endocrinology teams have been running a joint transition service since October 2000. A review of this service was undertaken in order to examine its effectiveness and aid service improvement.The details of all 81 patients, who had been through transitional care since October 2000, were acquired. Both their electronic records and adult endocrinology not...

ea0022p571 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Long-term morbidities in patients with Cushing's disease

Ntali Georgia , Siamatras Thomas , Komninos John , Karavitaki Niki , Wass John

Introduction: Cushing’s disease (CD) is a rare condition, associated with significant morbidities and potentially fatal, if untreated.Objective: To assess the long-term morbidities in a large series of patients with CD during a prolonged follow-up period.Patients and methods: All subjects with CD who presented/followed-up in our Department between 01/1967 and 06/2009 were studied. All information was collected as documented in...